Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Evolus Inc has a consensus price target of $22.63 based on the ratings of 9 analysts. The high is $27 issued by HC Wainwright & Co. on April 10, 2025. The low is $18 issued by Truist Securities on May 26, 2023. The 3 most-recent analyst ratings were released by Needham, BTIG, and HC Wainwright & Co. on May 8, 2025, April 17, 2025, and April 10, 2025, respectively. With an average price target of $23.33 between Needham, BTIG, and HC Wainwright & Co., there's an implied 136.17% upside for Evolus Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
05/08/2025 | Buy Now | 122.67% | Needham | Serge Belanger69% | $22 → $22 | Reiterates | Buy → Buy | Get Alert |
04/17/2025 | Buy Now | 112.55% | BTIG | Sam Eiber34% | → $21 | Initiates | → Buy | Get Alert |
04/10/2025 | Buy Now | 173.28% | HC Wainwright & Co. | Douglas Tsao49% | $27 → $27 | Reiterates | Buy → Buy | Get Alert |
04/09/2025 | Buy Now | 122.67% | Needham | Serge Belanger69% | $22 → $22 | Reiterates | Buy → Buy | Get Alert |
03/05/2025 | Buy Now | 153.04% | Barclays | Balaji Prasad64% | $22 → $25 | Maintains | Overweight | Get Alert |
03/05/2025 | Buy Now | 173.28% | HC Wainwright & Co. | Douglas Tsao49% | $27 → $27 | Reiterates | Buy → Buy | Get Alert |
03/05/2025 | Buy Now | 122.67% | Needham | Serge Belanger69% | $22 → $22 | Reiterates | Buy → Buy | Get Alert |
02/14/2025 | Buy Now | 173.28% | HC Wainwright & Co. | Douglas Tsao49% | $27 → $27 | Reiterates | Buy → Buy | Get Alert |
01/27/2025 | Buy Now | 122.67% | Barclays | Balaji Prasad64% | $20 → $22 | Maintains | Overweight | Get Alert |
01/22/2025 | Buy Now | 173.28% | HC Wainwright & Co. | Douglas Tsao49% | $27 → $27 | Reiterates | Buy → Buy | Get Alert |
01/21/2025 | Buy Now | 122.67% | Needham | Serge Belanger69% | $22 → $22 | Reiterates | Buy → Buy | Get Alert |
11/07/2024 | Buy Now | 173.28% | HC Wainwright & Co. | Douglas Tsao49% | $27 → $27 | Reiterates | Buy → Buy | Get Alert |
11/01/2024 | Buy Now | 173.28% | HC Wainwright & Co. | Douglas Tsao49% | $27 → $27 | Reiterates | Buy → Buy | Get Alert |
10/03/2024 | Buy Now | 173.28% | HC Wainwright & Co. | Douglas Tsao49% | $27 → $27 | Reiterates | Buy → Buy | Get Alert |
09/16/2024 | Buy Now | — | Cantor Fitzgerald | Louise Chen59% | — | Reiterates | → Overweight | Get Alert |
09/13/2024 | Buy Now | 102.43% | Barclays | Balaji Prasad64% | $16 → $20 | Maintains | Overweight | Get Alert |
09/13/2024 | Buy Now | 122.67% | Needham | Serge Belanger69% | $22 → $22 | Reiterates | Buy → Buy | Get Alert |
09/09/2024 | Buy Now | — | Cantor Fitzgerald | Louise Chen59% | — | Reiterates | → Overweight | Get Alert |
08/01/2024 | Buy Now | 173.28% | HC Wainwright & Co. | Douglas Tsao49% | $27 → $27 | Reiterates | Buy → Buy | Get Alert |
08/01/2024 | Buy Now | 122.67% | Needham | Serge Belanger69% | $22 → $22 | Reiterates | Buy → Buy | Get Alert |
06/20/2024 | Buy Now | — | Cantor Fitzgerald | Louise Chen59% | — | Reiterates | → Overweight | Get Alert |
05/21/2024 | Buy Now | 173.28% | HC Wainwright & Co. | Douglas Tsao49% | $27 → $27 | Reiterates | Buy → Buy | Get Alert |
05/08/2024 | Buy Now | 122.67% | Needham | Serge Belanger69% | $22 → $22 | Reiterates | Buy → Buy | Get Alert |
05/08/2024 | Buy Now | 173.28% | HC Wainwright & Co. | Douglas Tsao49% | $27 → $27 | Reiterates | Buy → Buy | Get Alert |
04/10/2024 | Buy Now | 122.67% | Needham | Serge Belanger69% | $22 → $22 | Reiterates | Buy → Buy | Get Alert |
03/08/2024 | Buy Now | 122.67% | Needham | Serge Belanger69% | $22 → $22 | Reiterates | Buy → Buy | Get Alert |
03/08/2024 | Buy Now | 173.28% | HC Wainwright & Co. | Douglas Tsao49% | $27 → $27 | Reiterates | Buy → Buy | Get Alert |
03/08/2024 | Buy Now | 153.04% | Stifel | Annabel Samimy66% | $23 → $25 | Reiterates | Buy → Buy | Get Alert |
03/08/2024 | Buy Now | 132.79% | Mizuho | Uy Ear60% | $20 → $23 | Maintains | Buy | Get Alert |
03/01/2024 | Buy Now | 173.28% | HC Wainwright & Co. | Douglas Tsao49% | $27 → $27 | Reiterates | Buy → Buy | Get Alert |
01/29/2024 | Buy Now | 61.94% | Barclays | Balaji Prasad64% | $10 → $16 | Upgrade | Equal-Weight → Overweight | Get Alert |
01/17/2024 | Buy Now | 173.28% | HC Wainwright & Co. | Douglas Tsao49% | $27 → $27 | Reiterates | Buy → Buy | Get Alert |
12/20/2023 | Buy Now | 122.67% | Needham | Serge Belanger69% | $22 → $22 | Reiterates | Buy → Buy | Get Alert |
08/03/2023 | Buy Now | 173.28% | HC Wainwright & Co. | Douglas Tsao49% | $16 → $27 | Maintains | Buy | Get Alert |
08/03/2023 | Buy Now | 122.67% | Needham | Serge Belanger69% | → $22 | Reiterates | Buy → Buy | Get Alert |
07/28/2023 | Buy Now | 61.94% | HC Wainwright & Co. | Douglas Tsao49% | → $16 | Reiterates | Buy → Buy | Get Alert |
06/07/2023 | Buy Now | 102.43% | Mizuho | Uy Ear60% | $17 → $20 | Maintains | Buy | Get Alert |
05/26/2023 | Buy Now | 82.19% | Truist Securities | Gregory Fraser29% | $14 → $18 | Maintains | Buy | Get Alert |
05/10/2023 | Buy Now | 122.67% | Needham | Serge Belanger69% | $18 → $22 | Maintains | Buy | Get Alert |
05/10/2023 | Buy Now | 61.94% | HC Wainwright & Co. | Douglas Tsao49% | $15 → $16 | Maintains | Buy | Get Alert |
03/09/2023 | Buy Now | 82.19% | Needham | Serge Belanger69% | → $18 | Reiterates | → Buy | Get Alert |
03/09/2023 | Buy Now | 51.82% | HC Wainwright & Co. | Douglas Tsao49% | → $15 | Reiterates | → Buy | Get Alert |
02/13/2023 | Buy Now | 82.19% | Needham | Serge Belanger69% | → $18 | Reiterates | → Buy | Get Alert |
01/19/2023 | Buy Now | 72.06% | Mizuho | Uy Ear60% | $15 → $17 | Maintains | Buy | Get Alert |
01/19/2023 | Buy Now | 102.43% | SVB Leerink | Marc Goodman75% | $18 → $20 | Maintains | Outperform | Get Alert |
06/23/2022 | Buy Now | 82.19% | Needham | Serge Belanger69% | → $18 | Initiates | → Buy | Get Alert |
05/13/2022 | Buy Now | 1.21% | Barclays | Balaji Prasad64% | $8 → $10 | Upgrade | Underweight → Equal-Weight | Get Alert |
05/12/2022 | Buy Now | 1.21% | Barclays | Balaji Prasad64% | $8 → $10 | Upgrade | Underweight → Equal-Weight | Get Alert |
The latest price target for Evolus (NASDAQ:EOLS) was reported by Needham on May 8, 2025. The analyst firm set a price target for $22.00 expecting EOLS to rise to within 12 months (a possible 122.67% upside). 22 analyst firms have reported ratings in the last year.
The latest analyst rating for Evolus (NASDAQ:EOLS) was provided by Needham, and Evolus reiterated their buy rating.
The last upgrade for Evolus Inc happened on January 29, 2024 when Barclays raised their price target to $16. Barclays previously had an equal-weight for Evolus Inc.
There is no last downgrade for Evolus.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Evolus, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Evolus was filed on May 8, 2025 so you should expect the next rating to be made available sometime around May 8, 2026.
While ratings are subjective and will change, the latest Evolus (EOLS) rating was a reiterated with a price target of $22.00 to $22.00. The current price Evolus (EOLS) is trading at is $9.88, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.